Advertisement
Advertisement

MASI

MASI logo

Masimo Corporation

171.43
USD
+3.82
+2.28%
Apr 02, 15:59 UTC -4
Closed
exchange

After-Market

156.91

-14.51
-8.47%

Masimo Corporation Profile

About

Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.

Info & Links

CEO

Michelle Brennan

Headquarters

52 DISCOVERY
IRVINE, CA 92618, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

www.masimo.com

Auditor

GRANT THORNTON LLP

Share holders

22

Employees

5,600

Masimo Corporation Statistics

Valuation Measures

Market Capitalization2

8.35B

Enterprise Value

8.90B

Enterprise Value/EBITDA(ttm)

-54.98

Price to Earnings Ratio(ttm)

45.91

Price to Sales(ttm)

4.65

Price to Book(mrq)

6.48

Price to Cash(ytd)

30.74

Profitability

Gross Margin(ttm)

48.32%

Operating Margin(ttm)

10.20%

Profit Margin(ttm)

-12.30%

Return on Equity(ttm)

14.98%

Return on Invested Capital(ttm)

-17.58%

Return on Assets(ttm)

6.95%

Income Statement

Revenue(ttm)

2.09B

Revenue Per Share(ttm)

38.82

Gross Profit(ttm)

1.00B

EBITDA(ttm)3

-161.80M

Net Income Available to Common(ttm)

-304.90M

Diluted EPS(ttm)

1.45

Share Statistics

Beta (5Y Monthly)

1.02

52-Week Change

18.37%

S&P 500 52-Week Change

8.82%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

53.95M

Dividend Yield

0.00%

Float4

48.35M

% Held by Insiders

9.70%

% Held by Institutions

85.96%

Balance Sheet

Total Cash(mrq)

177.60M

Total Cash Per Share(mrq)

3.29

Total Debt(mrq)

727.90M

Total Debt/Equity(mrq)

69.20%

Current Ratio(mrq)

1.98%

Quick Ratio(mrq)

1.11%

Book Value Per Share(mrq)

19.63

Cash Flow

Operating Cash Flow Per Share(ytd)

3.68

Free Cash Flow(ytd)

176.40M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement